COMP <GO>
CODA vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Coda Octopus Group Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CODA 7
— TMO 4
■ METRIC PARITY
LAST: $9.05 (-5.49%) • MKT CAP: $108.0M
options-implied-move
—
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CODA VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CODA | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.00% | 9.30% | +2.70 | CODA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.0x | 30.4x | -16.40 | CODA | /valuation <GO> |
| Free Cash Flow Yield | 5.59% | 2.40% | +3.19 | CODA | /fcf-yield <GO> |
| Operating Margin | 17.10% | 17.40% | -0.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 15.50% | 15.10% | +0.40 | CODA | /net-margins <GO> |
| Revenue Growth (YoY) | 30.70% | 3.90% | +26.80 | CODA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.35 | 4.50 | +8.85 | CODA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.2 | 62.9 | -30.73 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.9x | 36.3x | -14.40 | CODA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $108.0M | $262.22B | -$262.11B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CODA REV | TMO REV | CODA GROSS % | TMO GROSS % | CODA FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $26.6M | $44.56B | 66.5% | — | $6.0M | $6.29B |
| FY 2024 | $20.3M | $42.88B | 69.8% | — | $1.9M | $7.27B |
| FY 2023 | $19.4M | $42.86B | — | — | $2.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CODA // BETA —
TMO // BETA 0.94